Charles River Laboratories International, Inc.

NYSE:CRL

144.7 (USD) • At close June 6, 2025
Bedrijfsnaam Charles River Laboratories International, Inc.
Symbool CRL
Munteenheid USD
Prijs 144.7
Beurswaarde 7,107,041,790
Dividendpercentage 0%
52-weken bereik 91.86 - 254.15
Industrie Diagnostics & Research
Sector Healthcare
CEO Mr. James C. Foster J.D.
Website https://www.criver.com

An error occurred while fetching data.

Over Charles River Laboratories International, Inc.

Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The

Vergelijkbare Aandelen

Elanco Animal Health Incorporated logo

Elanco Animal Health Incorporated

ELAN

13.9 USD

Qiagen N.V. logo

Qiagen N.V.

QGEN

45.48 USD

Biohaven Pharmaceutical Holding Company Ltd. logo

Biohaven Pharmaceutical Holding Company Ltd.

BHVN

17.03 USD

Organon & Co. logo

Organon & Co.

OGN

9.56 USD

Universal Health Services, Inc. logo

Universal Health Services, Inc.

UHS

189.39 USD

Teleflex Incorporated logo

Teleflex Incorporated

TFX

122.8 USD

DaVita Inc. logo

DaVita Inc.

DVA

137.9 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)